Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survival
about
Can treating persistent inflammation limit protein energy wasting?Pros and cons of body mass index as a nutritional and risk assessment tool in dialysis patients.Muscle wasting in end-stage renal disease promulgates premature death: established, emerging and potential novel treatment strategies.Non-Invasive Biomarkers for Duchenne Muscular Dystrophy and Carrier Detection.Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney diseaseIncreased follistatin associated with decreased gait speed among old adults.
P2860
Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survival
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Circulating follistatin in pat ...... ty, inflammation, and survival
@ast
Circulating follistatin in pat ...... ty, inflammation, and survival
@en
Circulating follistatin in pat ...... ty, inflammation, and survival
@nl
type
label
Circulating follistatin in pat ...... ty, inflammation, and survival
@ast
Circulating follistatin in pat ...... ty, inflammation, and survival
@en
Circulating follistatin in pat ...... ty, inflammation, and survival
@nl
prefLabel
Circulating follistatin in pat ...... ty, inflammation, and survival
@ast
Circulating follistatin in pat ...... ty, inflammation, and survival
@en
Circulating follistatin in pat ...... ty, inflammation, and survival
@nl
P2093
P2860
P50
P356
P1476
Circulating follistatin in pat ...... ty, inflammation, and survival
@en
P2093
Björn Anderstam
Olof Heimbürger
Tetsu Miyamoto
P2860
P304
P356
10.2215/CJN.10511110
P577
2011-02-24T00:00:00Z